Established in 1999, the University of Colorado Cancer Center's Lung Cancer SPORE is a National Cancer Institute-funded program that aims to fast-track basic research findings to cancer patients and people at risk for cancer. Located at the CU Cancer Center and the Medical University of South Carolina, the Lung Cancer SPORE is funded through 2013 on a five-year grant totaling $11.5 million.
Our goal is to bring new ideas from the laboratory to the clinic and from the clinic to the lab, that can improve survival and quality of life while reducing the number of people who get lung cancer and who die from the disease.
Research is focused on developing biomarkers that can help doctors detect lung cancer earlier, assign prognosis and predict which patients will best respond to new types of treatments.
Current Funding Period: 2008-2013
Principal investigator: Dr. Paul A. Bunn, Jr., MD.
Locations: University of Colorado Cancer Center and Medical University of South Carolina